ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Bronchial hyperreactivity | 22.03.01.016 | - | - | Not Available |
Gingival erythema | 07.09.13.006 | 0.000334% | | Not Available |
Adverse reaction | 08.06.01.018 | - | - | Not Available |
Abdominal wall haemorrhage | 12.01.17.002; 24.07.02.036; 07.16.05.002 | 0.000334% | | Not Available |
Acute kidney injury | 20.01.03.016 | - | - | |
Lower urinary tract symptoms | 20.02.02.023 | - | - | Not Available |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | 0.000667% | | Not Available |
Administration site discomfort | 12.07.04.010; 08.02.04.010 | 0.000334% | | Not Available |
Adenocarcinoma of colon | 16.13.01.010; 07.21.01.008 | 0.001135% | | Not Available |
Bone cancer | 16.29.02.002; 15.09.03.012 | 0.000501% | | Not Available |
Breast cancer recurrent | 21.05.01.017; 16.10.01.009 | 0.000667% | | Not Available |
Metastases to bone | 16.22.02.005; 15.09.03.006 | 0.003337% | | Not Available |
Metastases to lymph nodes | 16.22.02.006; 01.09.01.015 | 0.000501% | | Not Available |
Terminal state | 08.01.03.079 | 0.001168% | | Not Available |
Metastases to thorax | 22.08.03.001; 16.22.02.028 | 0.000334% | | Not Available |
Breast cancer metastatic | 16.10.01.008; 21.05.01.016 | 0.000501% | | Not Available |
Arterial haemorrhage | 24.07.01.063 | 0.000334% | | Not Available |
Pyelocaliectasis | 20.01.06.011 | 0.000334% | | Not Available |
Oncologic complication | 16.32.03.025 | 0.000334% | | Not Available |
Metastases to pelvis | 21.07.04.008; 16.22.02.021 | - | - | Not Available |
Exposed bone in jaw | 15.02.04.034 | 0.000501% | | Not Available |
Abdominal lymphadenopathy | 07.11.01.018; 01.09.01.020 | 0.000334% | | Not Available |
Cerebral venous sinus thrombosis | 24.01.04.021; 17.08.03.006 | 0.000334% | | Not Available |
Gait inability | 17.02.05.069; 08.01.02.011 | 0.000334% | | Not Available |
Heavy menstrual bleeding | 21.01.03.005 | - | - | Not Available |
Implant site extravasation | 12.07.02.042; 08.02.02.042 | 0.001135% | | Not Available |
Intermenstrual bleeding | 21.01.01.015 | 0.000901% | | Not Available |
Myelosuppression | 01.03.03.015 | 0.000501% | | Not Available |
Vulvovaginal inflammation | 21.14.02.014 | - | - | Not Available |